FDA to Ease Way for Multidrug Regimens (MRK,AZN)
3/18/2010-The Food and Drug Administration is devising guidelines that could accelerate testing and approval of multidrug regimens for some of the world's most deadly diseases, The Wall Street Journal reported.
At least two pharmaceutical consortia are poised to take advantage of the forthcoming policy: a group of 10 drug companies and several nonprofit organizations convened by the Bill and Melinda Gates Foundation to develop medicines to fight tuberculosis; and pharmaceutical giants Merck & Co. (NYSE: MRK) and AstraZeneca PLC (NYSE: AZN), which are jointly testing two anticancer agents.
Many serious diseases, such as AIDS, tuberculosis and cancer, require multidrug combinations.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup
